Foghorn Therapeutics Inc. (FHTX) Balance Sheet
As of 2026-06-30 (10-Q), Foghorn Therapeutics Inc. (FHTX) reported total assets of $203.4M, total liabilities of $284.4M and shareholders' equity of -$81.0M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $68.1M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
FHTXFoghorn Therapeutics Inc.Follow FHTX — free
—
Price chart with a free account
- Market cap
- 118.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 92.8 | 101.1 | 52.2 | 80.3 | 55.5 | 80.9 | 68.1 | |
| Current assets | 190.7 | 459.6 | 351.4 | 240.2 | 249.6 | 163.2 | 170.0 | |
| Total assets | 255.6 | 519.8 | 404.9 | 285.9 | 284.0 | 198.1 | 203.4 | |
| Current liabilities | 18.8 | 48.7 | 55.2 | 58.4 | 67.0 | 59.7 | 50.6 | |
| Long-term debt | 19.7 | 0.0 | — | — | — | — | — | |
| Short-term debt | 0.0 | — | — | — | — | — | — | |
| Total liabilities | 109.4 | 422.9 | 404.8 | 363.1 | 329.5 | 306.6 | 284.4 | |
| Shareholders' equity | 146.2 | 96.9 | 0.1 | -77.2 | -45.5 | -108.5 | -81.0 |
USD millions · SEC XBRL
Foghorn Therapeutics Inc. — questions
- How much cash does Foghorn Therapeutics Inc. have?
- $68.1M in cash and cash equivalents as of 2026-06-30.
- What are Foghorn Therapeutics Inc.'s total assets?
- $203.4M as of 2026-06-30.
- What is Foghorn Therapeutics Inc.'s shareholders' equity?
- -$81.0M as of 2026-06-30.
Every figure on this page comes from Foghorn Therapeutics Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.